RAPP logo

RAPP
Rapport Therapeutics Inc

381
Mkt Cap
$1.8B
Volume
438,121.00
52W High
$42.27
52W Low
$7.73
PE Ratio
-15.25
RAPP Fundamentals
Price
$39.71
Prev Close
$37.72
Open
$38.35
50D MA
$34.09
Beta
1.46
Avg. Volume
338,466.98
EPS (Annual)
-$2.86
P/B
4.03
Rev/Employee
$0.00
$702.11
Loading...
Loading...

About

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
84

Frequently Asked Questions

What is Market Cap of Rapport Therapeutics Inc.?
What is the 52-week high for Rapport Therapeutics Inc.?
What is the 52-week low for Rapport Therapeutics Inc.?
What is Rapport Therapeutics Inc. stock price today?
What was Rapport Therapeutics Inc. stock price yesterday?
What is the PE ratio of Rapport Therapeutics Inc.?
What is the Price-to-Book ratio of Rapport Therapeutics Inc.?
What is the 50-day moving average of Rapport Therapeutics Inc.?
How many employees does Rapport Therapeutics Inc. have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available